Exscientia stock.

Like Recursion, Exscientia (NYSE: EXAI) uses AI in its approach to drug discovery.Unlike Recusion, Exscientia aims to develop bespoke drug solutions for patients. Exscientia was the first to bring ...

Exscientia stock. Things To Know About Exscientia stock.

This results in a target price of $34.4 (12.74 x 2.7) based on the current share price. This is a high target in view of current market conditions where stocks with negative earnings are being ...Transcript : Exscientia plc, Q3 2023 Earnings Call, Nov 09, 2023. Nov. 09. CI. Exscientia plc Reports Earnings Results for the Third Quarter and Nine Months Ended September …Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...Stocks / United States / Pharmaceuticals & Biotech Exscientia NasdaqGS:EXAI Stock Report Last Price US$6.10 Market Cap US$762.1m 7D 12.8% …

Jun 15, 2021 · Exscientia, based in Oxford, England, is paying 50 million euros ($60.6 million) in a combination of cash and shares for the Vienna-based Allcyte, according to a company press release.

Oxford-based Exscientia is a clinical-stage pharmatech that uses Artificial Intelligence (AI) to design and discover new drugs. The company just announced that BlackRock’s funds joined its Series C investment round, closing the round at $100 million (nearly £72 million). ... Robinhood to launch stock trading services in UK after failed ...One reason for this week's share growth was the company's first-quarter earnings report. Its reported revenue of $7.1 million was down 17.4% year over year, and its net loss was $46.6 million, 143 ...

Description. Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe and efficacious compounds for clinical ...The consensus price target hints at a 76.1% upside potential for Exscientia PLC Sponsored ADR (EXAI). While empirical research shows that this sought-after metric is hardly effective, an upward ... EXAI Exscientia plc Stock Price & Overview $6.12 0.02 ( +0.33%) 2:54 PM 12/01/23 NASDAQ | $USD | Realtime Summary Ratings Financials Earnings Dividends …This came just a few months after Recursion raised $436 million in an upsized IPO in April 2021 (Table 1). Exscientia, a pioneer in applying AI to small-molecule drug design, had a hefty IPO in ...A. While ratings are subjective and will change, the latest Exscientia ( EXAI) rating was a maintained with a price target of $12.00 to $10.00. The current price Exscientia ( EXAI) is trading at ...

Real time Exscientia Plc (EXAI) stock price quote, stock graph, news & analysis.

These 4 analysts have an average price target of $14.0 versus the current price of Exscientia at $6.1, implying upside. Below is a summary of how these 4 analysts rated Exscientia over the past 3 ...

Exscientia’s market value soared as shares of the artificial intelligence (AI) p harmaceutical-technology (pharmatech) company debuted on the stock market. Shares of the Oxford, England company rose more than 30% following Exscientia’s upsized initial public offering (IPO).A. While ratings are subjective and will change, the latest Exscientia ( EXAI) rating was a maintained with a price target of $12.00 to $10.00. The current price Exscientia ( EXAI) is trading at ... This reflects a positive earnings surprise of 26.19%. Look out for EXAI's next earnings release expected on March 28, 2024. For the next earning release, we expect the company to report earnings ...Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 2.78% so far this month. During the month of November, Exscientia PLC (ADR)’s stock price has reached a high of $6.10 and a low of $5.15. Over the last year, Exscientia PLC (ADR) has hit prices as high as $11.52 and as low as $4.09. Year to date ...Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 14.81% so far this month. During the month of November, Exscientia PLC (ADR)’s stock price has reached a high of $6.51 and a low of $4.95. Over the last year, Exscientia PLC (ADR) has hit prices as high as $11.52 and as low as $4.09. Year to date ...

When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...In the last 3 months, 7 analysts have offered 12-month price targets for Exscientia. The company has an average price target of $12.86 with a high of $14.00 and a low of $7.00. Below is a summary ...Jul 31, 2022 · About Exscientia Stock Founded 10 years ago, Exscientia describes itself as a pharmatech company with an end-to-end AI-powered platform that leverages experimental technologies for identifying potential disease targets and then designing drugs that would be the most effective and safe. Real time Exscientia Plc (EXAI) stock price quote, stock graph, news & analysis.Exscientia is a unique developmental concern using artificial intelligence to help identify promising drug compounds. ... The stock currently trades under $13.00 a share and sport a market ...Overview News Exscientia PLC ADR No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-1.42 Market Cap $718.11 M …

That was the dynamic behind artificial intelligence (AI)-powered healthcare-solutions provider Exscientia 's ( EXAI 1.15%) more than 6% leap in share price on Wednesday. That made the stock quite ...

Exscientia Plc American Depositary Shares (EXAI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.The Schrödinger Building Oxford Science Park, Oxford OX4 4GE . Phone: +44 (0) 1865 818941Exscientia Limited stock news. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites. ...Oct 4, 2021 · Exscientia was founded in 2012 by CEO Andew Hopkins, a 10-year Pfizer veteran. Prior to the initial stock offering, Exscientia had raised about $367 million, the company said in its filing. OXFORD, England-- (BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) announced today that it is expanding its technology management structure to accelerate application of Exscientia's innovative technologies to catalyse instrumental change in the way drug candidates are being discovered, designed and developed for patients in need …Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Exscientia PLC Sponsored ADR EXAI shares soared 13.5% in the last trading session to close at $5.29. The move was backed by solid volume with far more shares changing hands than in a normal session.Exscientia also has its eyes on up to $125 million in near-term milestones that form part of a potential $1.3 billion package. Sanofi originally made a smaller bet on Exscientia when it formed a ...Exscientia is an artificial intelligence-driven pharmatech company that discovers, designs, and develops drugs. The company's stock price, news, and …

Nov 17, 2023 · The latest Exscientia stock prices, stock quotes, news, and EXAI history to help you invest and trade smarter.

Nov 20, 2023 · Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 7.78% so far this month. During the month of November, Exscientia PLC (ADR)’s stock price has reached a high of $6.32 and a low of $4.95. Over the last year, Exscientia PLC (ADR) has hit prices as high as $11.52 and as low as $4.09. Year to date ...

We would like to show you a description here but the site won’t allow us.Jan 20, 2023 · Of course Exscientia may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying. Exscientia PLC Sponsored ADR EXAI closed the last trading session at $6.10, gaining 10.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10.25 indicates a 68% upside potential. The mean estimate comprises four …Exscientia Plc engages in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of therapeutic compounds. The company was founded by Andrew L. Hopkins in 2012 and is headquartered in Oxford, the United Kingdom. EXAI - Exscientia Plc ADR - Stock screener for investors and traders, financial ... Jul 12, 2023 · Shares of Exscientia (EXAI 2.18%) ... The stock is up more than 38% so far this year. So what. Exscienta is an AI-driven precision medicine company that focuses on oncology therapies. The clinical ... Sep 20, 2023 · Exscientia will receive an upfront payment of $20 million in cash and be eligible for milestone payments of up to $674 million in total. If a drug is commercialized, the company will also receive ... Revenue: Revenue for the three and nine months ended September 30, 2023 was $10.8 million and $21.6 million respectively, compared to $7.7 million and $24.9 million for the three and nine months ...Find out all the key statistics for Exscientia plc (EXAI), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta ...Nov 9, 2023 · Revenue: Revenue for the three and nine months ended September 30, 2023 was $10.8 million and $21.6 million respectively, compared to $7.7 million and $24.9 million for the three and nine months ... Exscientia is an AI-driven precision medicine company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective ...

Exscientia Plc engages in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of therapeutic compounds. The company was founded by Andrew L. Hopkins in 2012 and is headquartered in Oxford, the United Kingdom.About Exscientia Stock Founded 10 years ago, Exscientia describes itself as a pharmatech company with an end-to-end AI-powered platform that leverages experimental technologies for identifying potential disease targets and then designing drugs that would be the most effective and safe.View the latest Exscientia PLC ADR (EXAI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Instagram:https://instagram. best futures trading brokersnasdaq thtxon semiconductor newso realty stock dividend Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Track Exscientia Ltd - ADR (EXAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors stock to buy nowbest investment management software The company also recognized $1.5 million in net foreign exchange losses. Exscientia's stock showed mixed momentum, with a one-year decline of 24.04%, but positive growth over 3, 6, and 9 months. halliburton company stock Price target. 9.50 0.00 0.00%. The 4 analysts offering 1 year price forecasts for EXAI have a max estimate of — and a min estimate of —.Nov 9, 2023 · Revenue: Revenue for the three and nine months ended September 30, 2023 was $10.8 million and $21.6 million respectively, compared to $7.7 million and $24.9 million for the three and nine months ...